UC San Diego illegally uses race in admissions, Trump Justice Department alleges

This is read by an automated voice.Please report any issues or inconsistencies here.
See more from the L.A.Times in Google Search.
Set us as preferred UC San Diego’s medical school illegally used race in choosing which students to admit, discriminating against white and Asian applicants in favor of Black and Latino ones, the U.S.Department of Justice alleged Monday.The findings follow a roughly four-month investigation by the DOJ and makes the University of California, San Diego the latest medical school targeted by the Trump administration in a widening effort to root out what it alleges are widespread race-based admissions, a campaign that has focused heavily on California universities.
It follows similar actions against Stanford, UCLA and UC Davis, and escalates a legal conflict that could cost the UC system hundreds of millions of dollars in federal research funding if the two sides cannot reach an agreement.In the findings announced by its Civil Rights Division, the Justice Department said the medical school violated Title VI of the Civil Rights Act of 1964, which bars schools that receive federal money from discriminating based on race.The department said the school also went against the U.S.
Supreme Court’s 2023 ruling on affirmative action, which barred colleges from considering race in admissions.“Rather than rely on MCAT scores or GPA, San Diego Med’s shadow application process unlawfully judged applicants for admission based on their race,” Asst.Atty.
Gen.Harmeet K.
Dhillon said in a statement.“San Diego Med’s blatant efforts to prioritize race are illegal, and we will end these practices.” Politics California has been the target of more civil rights actions than any other state.
The civil rights division is led by California-native Harmeet Dhillon.The department said it wants to reach a voluntary agreement with the university to change its admissions practices, and said it will sue if those talks fail.Medical schools depen...